Augmentation and combination strategies in resistant depression.
A minority of patients with depression achieves remission with first-line antidepressant treatment; consequently, a second medication is often added to enhance the effects of the initial agent. The second medication may or may not be another antidepressant. Clinical trials have assessed the efficacy of many agents commonly used for augmentation or combination therapy, but well-designed, large trials with a clear definition of treatment resistance are needed.
Nelson
J Craig
JC
Department of Psychiatry, University of California School of Medicine, San Francisco, CA, USA.
D000928:Antidepressive Agents / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000188:drug therapy*; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D006801:Humans; D016896:Treatment Outcome
D000928:Antidepressive Agents